Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/229051a0 | DOI Listing |
Nat Commun
December 2024
Laboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA.
ZAP is an antiviral protein that binds to and depletes viral RNA, which is often distinguished from vertebrate host RNA by its elevated CpG content. Two ZAP cofactors, TRIM25 and KHNYN, have activities that are poorly understood. Here, we show that functional interactions between ZAP, TRIM25 and KHNYN involve multiple domains of each protein, and that the ability of TRIM25 to multimerize via its RING domain augments ZAP activity and specificity.
View Article and Find Full Text PDFMed J Armed Forces India
December 2024
Professor & Head (Urology), Bharati Vidyapeeth (Deemed to be University), Pune, India.
Background: Carcinoma prostate (CaP) is second most common cancer and sixth leading cause of cancer-related mortality among men worldwide. Prostate-specific antigen (sr. PSA) levels are prostate specific, not cancer specific.
View Article and Find Full Text PDFFront Fungal Biol
December 2024
Department of Plant Pathology and Microbiology, Texas A&M University, College Station, TX, United States.
is a globally significant genus of plant pathogens known for causing anthracnose across a diverse array of hosts. Notably, is a pathogen affecting maize. Annually, the global economic impact of this pathogen reaches billions of US dollars.
View Article and Find Full Text PDFCommun Biol
December 2024
Department of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.
The beta-rhizobial strain Paraburkholderia phymatum STM815 is noteworthy for its wide host range in nodulating legumes, primarily mimosoids (over 50 different species) but also some papilionoids. It cannot, however, nodulate soybean (Glycine max [L.] Merr.
View Article and Find Full Text PDFSci Rep
December 2024
School of Dentistry, University of California Los Angeles, 10833 Le Conte Ave., 73-022 CHS, Los Angeles, CA, 90095-1668, USA.
We developed a 4-parameter clinical assay using Electric Field Induced Release and Measurement (EFIRM) technology to simultaneously assess SARS-CoV-2 RNA (vRNA), nucleocapsid antigen, host binding (BAb) and neutralizing antibody (NAb) levels from a drop of saliva with performance that equals or surpasses current EUA-approved tests. The vRNA and antigen assays achieved lower limit of detection (LOD) of 100 copies/reaction and 3.5 TCID₅₀/mL, respectively.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!